Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDProtagenic Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
| Q1 2025 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q2 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Protagenic Therapeutics, Inc. Earnings Date And Information
Protagenic Therapeutics, Inc. last posted its earnings results on Monday, April 17th, 2023. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by $0.04. The company had revenue of 25,143 for the quarter and had revenue of 0 for the year. Protagenic Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.15 diluted earnings per share) and currently has a price-to-earnings ratio of -0.45. Protagenic Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Protagenic Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.14 | $25,143 | $25,143 | ||
| 08/14/2024 | Q2 2024 | -$0.36 | $0 | $0 | ||
| 05/15/2024 | Q1 2024 | -$0.39 | $0 | |||
| 05/14/2024 | Q4 2023 | -$0.38 | $3,200 | |||
| 11/14/2023 | Q3 2023 | -$0.32 | $0 | |||
| 08/14/2023 | Q2 2023 | -$0.28 | $0 | |||
| 05/15/2023 | Q1 2023 | -$0.17 | $0 | |||
| 04/17/2023 | Q4 2022 | $0.09 | -$0.14 | -0.23 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.21 | $0 | |||
| 08/11/2022 | Q2 2022 | -$0.15 | $0 | |||
| 05/13/2022 | Q1 2022 | -$0.31 | $0 | |||
| 04/07/2022 | Q4 2021 | -$0.09 | -$0.22 | -0.13 | $-480,510 | |
| 11/15/2021 | Q3 2021 | -$0.21 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.43 | $0 | |||
| 05/17/2021 | Q1 2021 | -$0.46 | $0 | |||
| 03/25/2021 | Q4 2020 | -$0.20 | $0 | |||
| 11/16/2020 | Q3 2020 | -$0.41 | $0 | |||
| 08/14/2020 | Q2 2020 | -$0.22 | $0 | |||
| 06/18/2020 | Q1 2020 | -$0.19 | $0 | |||
| 04/28/2020 | Q4 2019 | -$0.29 | $0 |
Protagenic Therapeutics, Inc. Earnings: FAQ's
When is Protagenic Therapeutics, Inc.'s earnings date?
Protagenic Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
How can I listen to Protagenic Therapeutics, Inc.'s earnings conference
call?
The conference call for Protagenic Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Protagenic Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Protagenic Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Protagenic Therapeutics, Inc. generate each year?
Protagenic Therapeutics, Inc. (:PTIX) has a recorded net income of $0. Protagenic Therapeutics, Inc. has generated $-1.15 earnings per share over the last four quarters.
What is Protagenic Therapeutics, Inc.'s price-to-earnings ratio?
Protagenic Therapeutics, Inc. (:PTIX) has a price-to-earnings ratio of -0.45 and price/earnings-to-growth ratio is -0.04.